Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance.
作者信息
Wilber Eli, Smith Gillian, Jacob Jesse T, Rebolledo Paulina A
机构信息
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Grady Health System, Atlanta, GA, USA.
出版信息
Antimicrob Steward Healthc Epidemiol. 2025 Aug 7;5(1):e179. doi: 10.1017/ash.2025.10072. eCollection 2025.
Abstract
摘要
相似文献
1
Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance.
Antimicrob Steward Healthc Epidemiol. 2025 Aug 7;5(1):e179. doi: 10.1017/ash.2025.10072. eCollection 2025.
2
Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China.
Emerg Microbes Infect. 2024 Dec;13(1):2332658. doi: 10.1080/22221751.2024.2332658. Epub 2024 Apr 3.
3
Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations.
Antimicrob Agents Chemother. 2025 Sep 3;69(9):e0053325. doi: 10.1128/aac.00533-25. Epub 2025 Jul 25.
4
Activity of New β-Lactam-β-Lactamase Inhibitor Combinations and Comparators against Clinical Isolates of Gram-Negative Bacilli: Results from the China Antimicrobial Surveillance Network (CHINET) in 2019.
Microbiol Spectr. 2022 Aug 31;10(4):e0185422. doi: 10.1128/spectrum.01854-22. Epub 2022 Jul 12.
5
activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations.
Microbiol Spectr. 2024 Jun 21;12(8):e0418123. doi: 10.1128/spectrum.04181-23.
6
Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study.
Lancet Infect Dis. 2024 Aug;24(8):856-867. doi: 10.1016/S1473-3099(24)00149-X. Epub 2024 Apr 25.
7
In vitro activity of the novel β-lactamase inhibitor FL058 combined with meropenem against KPC- or NDM-producing enterobacterales and Pseudomonas aeruginosa.
Eur J Clin Microbiol Infect Dis. 2025 Aug 12. doi: 10.1007/s10096-025-05232-3.
8
Prognosis and Outcome of Carbapenem-Resistant Enterobacterales Bacteremia Managed With Ceftazidime-Avibactam and Aztreonam Combination Therapy in Tawam Hospital, UAE: A Retrospective Study.
Cureus. 2025 Jun 10;17(6):e85689. doi: 10.7759/cureus.85689. eCollection 2025 Jun.
9
Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its "Sell-By Date" in an Era of New Antibiotics and Regional Carbapenemase Epidemiology.
Clin Infect Dis. 2020 Oct 23;71(7):1776-1782. doi: 10.1093/cid/ciaa122.
10
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections.
Infect Dis Ther. 2020 Dec;9(4):757-767. doi: 10.1007/s40121-020-00350-1. Epub 2020 Oct 5.
本文引用的文献
1
Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by .
Indian J Crit Care Med. 2023 Sep;27(9):655-662. doi: 10.5005/jp-journals-10071-24533.
2
Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
Clin Microbiol Infect. 2023 May;29(5):629-634. doi: 10.1016/j.cmi.2023.01.005. Epub 2023 Jan 12.
3
Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017-2019.
Antimicrob Resist Infect Control. 2022 Apr 9;11(1):57. doi: 10.1186/s13756-022-01097-9.
4
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States.
Microb Drug Resist. 2022 Apr;28(4):389-397. doi: 10.1089/mdr.2021.0106. Epub 2022 Feb 16.
5
Do Inpatient Antimicrobial Stewardship Programs Help Us in the Battle Against Antimicrobial Resistance?
Clin Infect Dis. 2021 Dec 6;73(11):e4454-e4462. doi: 10.1093/cid/ciaa1004.
6
Carbapenemase-Producing Organisms: A Global Scourge.
Clin Infect Dis. 2018 Apr 3;66(8):1290-1297. doi: 10.1093/cid/cix893.
Zotero 插件